• Mar. Gen 21st, 2025

glucagon-like peptide-1 receptor agonists

  • Home
  • Study identifies benefits, risks linked to popular weight-loss drugs. The journal Nature Medicine

Study identifies benefits, risks linked to popular weight-loss drugs. The journal Nature Medicine

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently…

Studies on risks of weight-loss drugs #DDW2024

Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with alcohol-use disorder…